Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
-
Sudan's El-Fasher under the RSF, destroyed and 'full of bodies'
-
From farms to court, climate-hit communities take on big polluters
-
Liverpool have 'moved on' from Salah furore, says upbeat Slot
-
Norway crown princess likely to undergo lung transplant
-
Iraq negotiates new coalition under US pressure
-
France's budget hits snag in setback for embattled PM
-
Putin hails Ukraine gains, threatens more, in annual press conference
-
US suspends green card lottery after Brown, MIT professor shootings
-
Chelsea's Maresca says Man City link '100 percent' speculation
-
Dominant Head moves into Bradman territory with fourth Adelaide ton
-
Arsenal battle to stay top of Christmas charts
-
Mexican low-cost airlines Volaris and Viva agree to merger
-
Border casinos caught in Thailand-Cambodia crossfire
-
Australia's Head slams unbeaten 142 to crush England's Ashes hopes
-
Epstein files due as US confronts long-delayed reckoning
-
'Not our enemy': Rush to rearm sparks backlash in east Germany
-
West Indies 110-0, trail by 465, after Conway's epic 227 for New Zealand
-
Arsonists target Bangladesh newspapers after student leader's death
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Tears at tribute to firefighter killed in Hong Kong blaze
-
Seahawks edge Rams in overtime thriller to seize NFC lead
-
Teenager Flagg leads Mavericks to upset of Pistons
-
Australia's Head fires quickfire 68 as England's Ashes hopes fade
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
Conway falls for 227 as New Zealand pass 500 in West Indies Test
-
'We are ghosts': Britain's migrant night workers
-
Asian markets rise as US inflation eases, Micron soothes tech fears
-
Giant lanterns light up Christmas in Catholic Philippines
-
TikTok: key things to know
-
Putin, emboldened by Ukraine gains, to hold annual presser
-
Deportation fears spur US migrants to entrust guardianship of their children
-
Upstart gangsters shake Japan's yakuza
-
Trump signs $900 bn defense policy bill into law
-
Stokes's 83 gives England hope as Australia lead by 102 in 3rd Test
-
Go long: the rise and rise of the NFL field goal
-
Australia announces gun buyback, day of 'reflection' after Bondi shooting
-
New Zealand Cricket chief quits after split over new T20 league
-
England all out for 286, trail Australia by 85 in 3rd Test
-
Australian announces gun buyback, day of 'reflection' after Bondi shooting
-
Joshua takes huge weight advantage into Paul fight
-
TikTok signs joint venture deal to end US ban threat
-
Conway's glorious 200 powers New Zealand to 424-3 against West Indies
-
Barnwell Industries, Inc. Reports Results for Its Fourth Quarter and Year Ended September 30, 2025
-
What is the Best Scar Removal Cream for C-section?
-
Agronomics Limited Announces Dissolution of Meatable
-
Agronomics Limited Announces Liberation Bioindustries Series A1 Equity Round
-
The European "Anti-Trend" Has Arrived
-
LEXINOVA Trading Center Releases New Brand Positioning Strategy Focused on Global Compliance and Institutional-Grade Infrastructure
-
Guardian Metal Resources PLC Announces Pilot Mountain Pre-Feasibility Progress Update
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store Ltd. This significant milestone underscores the strategic value of the agreement and demonstrates the potential of Bionoid's growth strategy.
The LOI with Your Supplement Supply Store Ltd. represents a pivotal step in Bionoid's expansion into the health and wellness e-commerce sector. Under the terms of the agreement, Bionoid retains all revenue generated during the transition period prior to the finalization of the Asset Purchase Agreement (APA). This structure has enabled Bionoid to capture immediate value while ensuring a seamless integration process.
"The revenue generated from this agreement is a testament to the strength of our strategic partnerships and our ability to drive results even before completing the acquisition process," said Wayne Cockburn, CEO of Bionoid Pharma, Inc. "This success reinforces our commitment to building a robust e-commerce presence in the health and wellness sector and highlights the potential for future growth as we continue to execute our long-term vision."
Bionoid's strategy focuses on acquiring high-value e-commerce platforms and leveraging its proprietary AI Maverick technology to optimize customer engagement and operational efficiency. The success of this initial revenue generation further positions the company as a leader in the health and wellness market.
About Bionoid Pharma, Inc.
Bionoid Pharma, Inc. is a forward-thinking health and wellness company dedicated to expanding revenue streams and enhancing brand presence through strategic acquisitions and advanced AI technology. Its proprietary AI Maverick platform supports the company's mission to deliver innovative, AI-driven solutions that foster customer loyalty, operational excellence, and sustainable growth.
Stay connected:
Website: BionoidPhama.com
OTC Markets: BINP
X (formally Twitter)
For further information, contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
Email: [email protected]
SOURCE: Bionoid Pharma, Inc.
O.Karlsson--AMWN
